Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer

作者: Mariana Brait , Myriam Loyo , Eli Rosenbaum , Kimberly L. Ostrow , Alina Markova

DOI: 10.4161/EPI.20524

关键词: DNA methylationBisulfite sequencingCancer researchThyroidMethylationThyroid cancerCandidate geneEpigeneticsCancerBiology

摘要: Our aim was to comprehensively analyze promoter hypermethylation of a panel novel and known methylation markers for thyroid neoplasms establish their relationship with BRAF mutation clinicopathologic parameters cancer. A cohort tumors, consisting 44 cancers benign lesions, as well 15 samples adjacent normal tissue, evaluated hypermethylation. Genes quantitative specific PCR (QMSP) were selected by candidate gene approach. Twenty-two genes tested: TSHR, RASSF1A, RARβ2, DAPK, hMLH1, ATM, S100, p16, CTNNB1, GSTP1, CALCA, TIMP3, TGFsR2, THBS1, MINT1, MT1G, PAK3, NISCH, DCC, AIM1 KIF1A. The PCR-based "mutector assay" used detect mutation. All p values reported are two sided. Considerable overlap seen in the among different tissue groups. Significantly higher frequency level observed KIF1A RARs2 cancer compared tumors. negative correlation between RASSF1A methylation, positive accordance previous results. In addition, TIMP3 marginal DCC observed. present study constitutes comprehensive profile neoplasia shows that results must be analyzed tissue-specific manner identify clinically useful markers. Integration genetic epigenetic changes will help relevant biologic pathways drive its development.

参考文章(45)
D Gozuacik, S Bialik, T Raveh, G Mitou, G Shohat, H Sabanay, N Mizushima, T Yoshimori, A Kimchi, DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death Cell Death & Differentiation. ,vol. 15, pp. 1875- 1886 ,(2008) , 10.1038/CDD.2008.121
Y. Cohen, M. Xing, E. Mambo, Z. Guo, G. Wu, B. Trink, U. Beller, W. H. Westra, P. W. Ladenson, D. Sidransky, BRAF Mutation in Papillary Thyroid Carcinoma Journal of the National Cancer Institute. ,vol. 95, pp. 625- 627 ,(2003) , 10.1093/JNCI/95.8.625
Nicole E. Benoit, David Goldenberg, Shirley X. Deng, Eli Rosenbaum, Yoram Cohen, Joseph A. Califano, William H. Shackelford, Xiao B. Wang, David Sidransky, Colorimetric approach to high-throughput mutation analysis BioTechniques. ,vol. 38, pp. 635- 639 ,(2005) , 10.2144/05384PF01
Kimberly D. Siegmund, Adi F. Gazdar, Arvind K. Virmani, Jeffrey A. Tsou, Tiffany I. Long, Ite A. Laird-Offringa, Linda Y. C. Shen, Peter W. Laird, Hierarchical Clustering of Lung Cancer Cell Lines Using DNA Methylation Markers Cancer Epidemiology, Biomarkers & Prevention. ,vol. 11, pp. 291- 297 ,(2002)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
Reinhard Dammann, Chun Li, Jung-Hoon Yoon, Philip L. Chin, Steven Bates, Gerd P. Pfeifer, Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genetics. ,vol. 25, pp. 315- 319 ,(2000) , 10.1038/77083
Patrick Mehlen, Shahrooz Rabizadeh, Scott J. Snipas, Nuria Assa-Munt, Guy S. Salvesen, Dale E. Bredesen, The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis Nature. ,vol. 395, pp. 801- 804 ,(1998) , 10.1038/27441
Kwok-Wai Lo, Joseph Kwong, Angela Bik-Yu Hui, Sylvia Yat-Yee Chan, Ka-Fai To, Andrew Siu-Chung Chan, Lillian Shuk-Nga Chow, Peter ML Teo, Philip J Johnson, Dolly Poon Huang, None, High Frequency of Promoter Hypermethylation of RASSF1A in Nasopharyngeal Carcinoma Cancer Research. ,vol. 61, pp. 3877- 3881 ,(2001)
Manel Esteller, Manel Esteller, Stephen B. Baylin, James G. Herman, Paul G. Corn, A Gene Hypermethylation Profile of Human Cancer Cancer Research. ,vol. 61, pp. 3225- 3229 ,(2001)
Nicole Benoit, David Sidransky, Michael Kim, Ashok N. Reddy, Joseph A. Califano, Rodney Taylor, John Clinger, Wei W. Jiang, Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Research. ,vol. 63, pp. 7694- 7698 ,(2003)